Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
IGC Pharma, Inc. (IGC) had Cash Flow from Financial Activities of $0.71M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.32M |
|
$-2.40M |
|
$0.26M |
|
$0.06M |
|
$2.77M |
|
$-2.46M |
|
$0.06M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.40M |
|
$-2.46M |
|
$-2.46M |
|
98.16M |
|
98.16M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.15M |
|
$2.10M |
|
$8.04M |
|
$9.19M |
|
$2.87M |
|
$0.19M |
|
$0.19M |
|
$3.06M |
|
$6.12M |
|
$0.85M |
|
$6.12M |
|
98.80M |
|
| Cash Flow Statement Financials | |
$-1.22M |
|
$-0.17M |
|
|
Cash Flow from Financial Activities |
$0.71M |
$0.90M |
|
$0.21M |
|
$-0.69M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.40 |
|
-- |
|
-- |
|
0.03 |
|
0.15 |
|
17.35% |
|
-775.39% |
|
-775.39% |
|
-- |
|
-757.73% |
|
-757.73% |
|
$-1.22M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.41 |
|
8.57 |
|
10.50 |
|
-39.24% |
|
-281.59% |
|
-26.15% |
|
-38.05% |
|
$0.06 |
|
$-0.01 |
|
$-0.01 |
|